Moderna Added 45 Billion Dollars in a Day on a Melanoma Vaccine Result with No Effect Size Disclosed

Moderna and Merck’s melanoma vaccine met its Phase 3 goals, but no effect size was released, and some analysts called the market reaction excessive.

Have A Referral?